159 related articles for article (PubMed ID: 12373530)
1. Modulation of glutamate receptors: strategies for the development of novel antidepressants.
Skolnick P
Amino Acids; 2002; 23(1-3):153-9. PubMed ID: 12373530
[TBL] [Abstract][Full Text] [Related]
2. Glutamate hypothesis of depression and its consequences for antidepressant treatments.
Musazzi L; Treccani G; Popoli M
Expert Rev Neurother; 2012 Oct; 12(10):1169-72. PubMed ID: 23082730
[No Abstract] [Full Text] [Related]
3. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article.
Chizh BA
Amino Acids; 2002; 23(1-3):169-76. PubMed ID: 12373533
[TBL] [Abstract][Full Text] [Related]
4. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
Chaki S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
[TBL] [Abstract][Full Text] [Related]
5. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
Paslakis G; Gass P; Deuschle M
Fortschr Neurol Psychiatr; 2011 Apr; 79(4):204-12. PubMed ID: 21117011
[TBL] [Abstract][Full Text] [Related]
6. New perspectives on glutamate receptor antagonists as antidepressants.
Chung C
Arch Pharm Res; 2012 Mar; 35(4):573-7. PubMed ID: 22553049
[TBL] [Abstract][Full Text] [Related]
7. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia.
Heresco-Levy U
Expert Opin Emerg Drugs; 2005 Nov; 10(4):827-44. PubMed ID: 16262565
[TBL] [Abstract][Full Text] [Related]
8. Glutamate-based antidepressants: preclinical psychopharmacology.
Pilc A; Wierońska JM; Skolnick P
Biol Psychiatry; 2013 Jun; 73(12):1125-32. PubMed ID: 23453290
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives on the development of non-biogenic amine-based antidepressants.
Skolnick P; Legutko B; Li X; Bymaster FP
Pharmacol Res; 2001 May; 43(5):411-23. PubMed ID: 11394932
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic mechanisms in different disease states: overview and therapeutical implications -- an introduction.
Tzschentke TM
Amino Acids; 2002; 23(1-3):147-52. PubMed ID: 12373529
[TBL] [Abstract][Full Text] [Related]
11. Beyond monoamine-based therapies: clues to new approaches.
Skolnick P
J Clin Psychiatry; 2002; 63 Suppl 2():19-23. PubMed ID: 15453010
[TBL] [Abstract][Full Text] [Related]
12. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors.
Musazzi L; Treccani G; Mallei A; Popoli M
Biol Psychiatry; 2013 Jun; 73(12):1180-8. PubMed ID: 23273725
[TBL] [Abstract][Full Text] [Related]
13. Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex.
Világi I; Dobó E; Borbély S; Czégé D; Molnár E; Mihály A
Exp Neurol; 2009 Sep; 219(1):136-45. PubMed ID: 19445932
[TBL] [Abstract][Full Text] [Related]
14. [New therapeutic options in Alzheimer's disease].
García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
[TBL] [Abstract][Full Text] [Related]
15. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
Bridges RJ; Esslinger CS
Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
[TBL] [Abstract][Full Text] [Related]
16. Can monoamine-based therapies be improved?
Demitrack MA
J Clin Psychiatry; 2002; 63 Suppl 2():14-8. PubMed ID: 15453009
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and the glutamate receptor system: a target for drug action.
Bleich S; Römer K; Wiltfang J; Kornhuber J
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S33-40. PubMed ID: 12973748
[TBL] [Abstract][Full Text] [Related]
18. Development of glutamate receptors in auditory neurons from long-term organotypic cultures of the embryonic chick hindbrain.
Diaz C; Martinez-Galan JR; Juiz JM
Eur J Neurosci; 2009 Jan; 29(2):213-30. PubMed ID: 19200228
[TBL] [Abstract][Full Text] [Related]
19. [Protection of excitotoxicity].
Kwak S
No To Shinkei; 1996 Dec; 48(12):1077-85. PubMed ID: 8990475
[No Abstract] [Full Text] [Related]
20. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
